All of Us Research Program
Do you want to change the future of health? The Froedtert & MCW health network is part of the National Institutes of Health All of Us Research Program. It has a simple mission — speed up health research breakthroughs. To do this, All of Us is asking one million people to share their health information. Learn how you can help make a difference by joining the All of Us Research Program.
This project is being done to determine if the experimental drug AL001 is effective and safe in treating individuals who have a known progranulin gene mutation that causes FTD, when compared to placebo (a solution that contains no active AL001 drug).
- Known pre-symptomatic or symptomatic carriers of a heterozygous loss-of-function GRN mutation causative of FTD
- 18 – 85 years old
- Suitable study partner
PLEASE consult Dr. Granadillo to send patient for genetic counseling and testing for the GRN mutation. This is for clinical purposes and not part of the research ...
The ADvance II Study is researching the use of deep brain stimulation of the fornix (known as DBS-f), a place in the brain that plays a central role in memory, in people with Alzheimer’s disease.
DBS-f uses a surgically implanted medical device, similar to a heart pacemaker, to deliver mild electrical pulses to precisely targeted areas of the brain.
- At least 65 years old with Probable Alzheimer’s disease mild
- Has an available caregiver or other appropriate knowledgeable informant
- Must be a good surgical candidate for placement of a deep brain stimulator
- Eit ...
A Phase III, Randomized Study Of Nivolumab (OPDIVO) Plus AVD Or Brentuximab Vedotin (ADCETRIS) Plus AVD In Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Phase 1/1b Study To Evaluate The Safety And Activity Of TTX-030 (Anti-CD39) In Combination With Budigalimab And/Or Chemotherapy In Subjects With Advanced Solid Tumors
To test the safety of TTX-030 combination therapy in various cancer types
To see if TTX-030 combination therapy works against various cancer types
To see how much TTX-030 combination therapy is in the blood at specific times after dosing and how the body eliminates TTX-030
To see what effects TTX-030 combination therapy has on the body